How to Use Orforglipron
Complete guide to Orforglipron dosing, administration, timing, and protocol recommendations.
Quick Overview
An oral non-peptide GLP-1 receptor agonist. FDA approved April 1, 2026 under the brand name Foundayo - the first daily oral GLP-1 pill for weight loss. Distribution began April 6, 2026. FDA subsequently requested additional post-approval safety data.
Dosing Guidelines
Common Dose
Limited community data available
Frequency
See research protocols
Dose Range
See research dosing
Note: Not yet FDA approved (decision expected April 2026). If approved, Lilly has announced LillyDirect pricing: $149-$399/month self-pay depending on dose.
Administration Method
Oral tablet daily
Best Time to Take
Before bed or morning (fasted)
GH-related peptides work best on an empty stomach to maximize growth hormone release.
Protocol Duration
Long-term use expected
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Diarrhea (19-26%)
- •Nausea (13-18%)
- •Vomiting
- •GI events mild-moderate
- •Pulse increase
Frequently Asked Questions
What is the recommended dose for Orforglipron?
Limited community data available
How do you administer Orforglipron?
Oral tablet daily
When is the best time to take Orforglipron?
Before bed or morning (fasted)
How long should you use Orforglipron?
Long-term use expected
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.